高效空气过滤器预防野火相关哮喘并发症的成本效果研究
该研究用马尔可夫模型评估加拿大不列颠哥伦比亚省(BC)政府补贴高效空气过滤器(HEPA)在5年(2018-2022)内管理哮喘、预防急性发作的成本效果。基础分析中每人成本增加83.34美元(SE 1.03美元)、质量调整生命年(QALY)增加0.0011(SE 0.0001),全省平均增量成本效果比为74,652美元/QALY(SE 3,517美元),各卫生服务区差异较大。结论认为补贴最高达过滤器成本三分之二通常具有成本效果,全额补贴仅在Kootenay Boundary具有成本效果。
要点
- HEPA过滤器每QALY增量成本约74,652美元,各卫生服务区从40,509到89,206美元不等
- 5年内预计预防4,418次需全身糖皮质激素的急性发作、643次急诊就诊和425次住院
- 补贴达过滤器成本三分之二通常具有成本效果,全额补贴仅在Kootenay Boundary具有成本效果
核心结论
- 在BC省,HEPA过滤器补贴用于野火烟雾相关哮喘管理的成本效果因地区而异。
- 补贴最高达过滤器成本三分之二通常具有成本效果,全额补贴仅在Kootenay Boundary具有成本效果。
研究设计与样本
- 采用马尔可夫模型分析哮喘控制、急性发作严重程度和死亡健康状态,回顾性时间范围为5年(2018-2022)。
- 模型纳入加拿大优化统计烟雾暴露模型估算的野火烟雾来源PM2.5浓度( aerodynamic diameter ⩽2.5 μm)及相关文献。
- 基础分析假设持续使用HEPA过滤器,按每个卫生服务区(HSDA)计算不同补贴方案的成本与QALY。
主要发现
- 基础分析中HEPA过滤器使用使每人成本增加83.34美元(SE 1.03美元)、QALY增加0.0011(SE 0.0001)。
- BC各HSDA平均增量成本效果比为74,652美元/QALY(SE 3,517美元),各HSDA增量成本效果比范围为40,509至89,206美元/QALY。
- 全省5年时间范围内预计预防4,418次需全身糖皮质激素的急性发作、643次急诊就诊和425次住院。
- 全额补贴在BC的16个HSDA中有1个具有成本效果,各HSDA具有成本效果的概率范围为0.1%至74.8%。
- 100美元补贴在大多数HSDA具有成本效果。
关键数值与推荐
- 基础分析:每人成本增加83.34美元(SE 1.03美元),QALY增加0.0011(SE 0.0001)。
- 平均增量成本效果比74,652美元/QALY(SE 3,517美元),HSDA范围40,509至89,206美元/QALY。
- 全额补贴在16个HSDA中1个具有成本效果,成本效果概率0.1%至74.8%。
- 100美元补贴在大多数HSDA具有成本效果。
临床怎么用
- 在BC省可优先考虑对HEPA过滤器提供最高达成本三分之二的补贴以管理野火烟雾相关哮喘。
- 全额补贴可考虑仅用于Kootenay Boundary等成本效果较好的地区。
- 100美元补贴在大多数HSDA具有成本效果,可作为补贴设计的参考。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Air pollution caused by wildfire smoke is linked to adverse health outcomes, especially for people living with asthma. Objectives: To evaluate whether government rebates for high-efficiency particulate air (HEPA) filters, which reduce concentrations of smoke particles indoors, are cost effective in managing asthma and preventing exacerbations in British Columbia (BC), Canada. Methods: We used a Markov model to analyze health states for asthma control, exacerbation severity, and death over a retrospective time horizon of 5 years (2018-2022). Concentrations of wildfire smoke-derived particulate matter with an aerodynamic diameter ⩽2.5 μm (PM2.5) from the Canadian Optimized Statistical Smoke Exposure Model and relevant literature informed the model. The base-case analysis assumed continuous use of a HEPA filter. Costs and quality-adjusted life-years (QALYs) resulting from varying rebates were computed for each Health Service Delivery Area (HSDA). Measurements and Main Results: In the base-case analysis, HEPA filter use resulted in increased costs of $83.34 (SE, $1.03) and increased QALYs of 0.0011 (SE, 0.0001) per person. The average incremental cost-effectiveness ratio among BC HSDAs was $74,652/QALY (SE, $3,517), with incremental cost-effectiveness ratios ranging from $40,509 to $89,206 per QALY in HSDAs. Across the province, the intervention was projected to prevent 4,418 exacerbations requiring systemic corticosteroids, 643 emergency department visits, and 425 hospitalizations during the 5-year time horizon. A full rebate was cost effective in 1 of the 16 HSDAs across BC. The probability of cost-effectiveness ranged from 0.1% to 74.8% across HSDAs. A $100 rebate was cost effective in most HSDAs. Conclusions: The cost-effectiveness of HEPA filters in managing wildfire smoke-related asthma issues in BC varies by region. Government rebates up to two-thirds of the filter cost are generally cost effective, with a full rebate being cost effective only in Kootenay Boundary.
引用
- Adibi, Barn, Shellington, et al. High-Efficiency Particulate Air Filters for Preventing Wildfire-related Asthma Complications: A Cost-Effectiveness Study. Am J Respir Crit Care Med. 2024. PMID: 37917367. doi:10.1164/rccm.202307-1205OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。